Atea Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US04683R1068

SecurityAVIR / Atea Pharmaceuticals, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership116,381 shares
Latest Disclosed Value $ 345,651
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.49% increase in ownership of AVIR / Atea Pharmaceuticals, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 116,381 shares of Atea Pharmaceuticals, Inc. (US:AVIR) valued at $345,652 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 115,811 shares of Atea Pharmaceuticals, Inc.. This represents a change in shares of 0.49% during the quarter. The current value of the position is $494,619 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP ATEA PHARMACEUTICALS EC US04683R1068 116,381 570 0.49 346 -1.43 0.0046
2025-04-25 2025-02-28 NP ATEA PHARMACEUTICALS EC US04683R1068 115,811 3,078 2.73 351 -9.09 0.0047
2025-01-27 2024-11-30 NP ATEA PHARMACEUTICALS EC US04683R1068 112,733 798 0.71 386 -10.47 0.0052
2024-10-29 2024-08-31 NP ATEA PHARMACEUTICALS EC US04683R1068 111,935 1,083 0.98 431 5.91 0.0064
2024-07-26 2024-05-31 NP ATEA PHARMACEUTICALS EC US04683R1068 110,852 1,425 1.30 407 -13.80 0.0064
2024-04-24 2024-02-29 NP ATEA PHARMACEUTICALS EC US04683R1068 109,427 21,910 25.04 472 80.46 0.0079
2024-01-24 2023-11-30 NP ATEA PHARMACEUTICALS EC US04683R1068 87,517 11,876 15.70 262 2.76 0.0050
2023-10-27 2023-08-31 NP ATEA PHARMACEUTICALS EC US04683R1068 75,641 75,641 254 0.0050
2022-01-25 2021-11-30 NP ATEA PHARMACEUTICALS EC US04683R1068 0 -23,714 -100.00 0 -100.00
2021-10-26 2021-08-31 NP ATEA PHARMACEUTICALS EC US04683R1068 23,714 4,775 25.21 705 82.38 0.0154
2021-07-22 2021-05-31 NP ATEA PHARMACEUTICALS EC US04683R1068 18,939 60 0.32 387 -72.86 0.0096
2021-04-23 2021-02-28 NP ATEA PHARMACEUTICALS EC US04683R1068 18,879 1,125 6.34 1,423 140.61 0.0371
2021-01-20 2020-11-30 NP ATEA PHARMACEUTICALS EC US04683R1068 17,754 17,754 592 0.0177
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.